About the Workshop
Organizers
Dr. Ghada Zamzmi
Heartflow, USA
(ex FDA staffer)
Heartflow, USA
(ex FDA staffer)
Dr. Mariia Sidulova
Medtronic, USA
(ex FDA staffer)
Medtronic, USA
(ex FDA staffer)
Dr. Thijs Kooi
Lunit Inc, South Korea
Lunit Inc, South Korea
Dr. Xiaoxiao Li
UBC, Canada
UBC, Canada
Dr. Annika Reinke
DKFZ, Germany
DKFZ, Germany
Advisory Board
Dr. Ehsan Adeli
Stanford, USA
Stanford, USA
Dr. Marzyeh Ghassemi
MIT, USA
MIT, USA
Dr. Lena Maier-Hein
Heidelberg University, Germany
Heidelberg University, Germany
Dr. Federica Zanca
EISMEA – European Commission, Belgium
EISMEA – European Commission, Belgium
Why this Workshop?
The accelerating pace of AI technological advancements primarily centered on evolving network architectures is outpacing the development of corresponding evaluation and regulatory frameworks. This disconnect creates a widening gap that not only hinders the effective integration of AI into healthcare but also raises serious concerns about patient safety. Without robust evaluation and regulatory mechanisms, AI models may fail to meet the reliability and usability standards required for clinical deployment.While many MICCAI workshops have explored themes such as technical developments, there remains a noticeable gap in addressing evaluation pitfalls, deployment challenges, and regulatory-science issues. If left unaddressed, these challenges can affect patient safety and outcomes.
Questions?
Reach out to us at: BRIDGERegSci@gmail.com